C. K. Miller et al. / Bioorg. Med. Chem. Lett. xxx (2015) xxx–xxx
3
Br
I
Br
S
ii a - b
i
S
R
HO
HO
O
O
26
R = NHMe
O
24
25
R = NMe2 27
O
O
O
B
O
O
S
O
iii
28
R
O
29
R = NHMe
(Table 1)
R = NMe2 30 (Table 1)
Scheme 2. Reagents and conditions: (i) 2-bromothiophene, DMSO, KF, PdCl2(PPh3)2, AgNO3, 100 °C, N2, 2 h; (ii) (a) THF, pyridine, pentafluorophenyltrifluoroacetate, rt, 2 h;
(b) THF, methylamine (40% soln.) or dimethylamine, rt, 2–3 h; (iii) toluene/EtOH, 2 M Na2CO3, PdCl2(dppf)ꢁCH2Cl2, 85–90 °C, N2, 2–6 h.
esterification from their native carboxylic acids in the presence of
EtOH and catalytic H2SO4, using conventional methodology
(Scheme 3). The sequential step was carried out as for carboxylic
acid analogue 25 (refer to Scheme 2) affording ethyl esters 36–
38, these in turn were then coupled with key boronate ester 28
via a Suzuki reaction to give diarylthiophene esters 39–41 in good
to excellent yields. Hydrolysis of the resulting esters with 2 M
NaOH in MeOH under reflux conditions, gave bis-carboxylic acid
intermediates 42–44, respectively. Subsequent dehydration to
isobenzofuran-1(3H)-one precursors 45–47 was achieved quanti-
tatively using a mixture of TFA/CH2Cl2 (1:1) at room temperature
for approximately 3–4 h. Target compounds 48–57 were then syn-
thesised utilising a variety of amide-coupling strategies (Scheme 3).
Carboxamide 48 was prepared successfully in 57% yield going via
the analogous PFP-active ester intermediate as employed for car-
boxamides 26 and 27 (refer to Scheme 2). Compounds 49–54,
which contain various extended neutral and basic side-chains
appended to the 4-carboxamide moiety, were accessed through
treatment of the corresponding acid precursor with DCC and cat-
alytic HOBt at elevated temperatures. Target compounds 55
(48%), 56 (80%), and 57 (38%), all of which contain a 3-substi-
tuted-phenyl primary amine, were accessed through an EDCI/
HOBt-mediated amide-coupling in the presence of anhydrous
DMF at 0 °C to room temperature over 1–2 h.
activity.8 This approach is illustrated in Figure 2 and highlights
key objectives which include removal of the Michael acceptor
and elimination of isomeric mixtures.
For the current study we elected to retain the isobenzofuranone
C-subunit of 2 as this class is generally more potent than the cor-
responding isoindolinones8 which were originally introduced on
the assumption they would be less susceptible to hydrolysis. How-
ever subsequent stability studies showed no clear advantage with
both the isoindolinones and isobenzofuranones showing variable
half-lives in vitro (microsome stability) and in vivo.11 Parent com-
pound (6) was employed as a start point for the replacement of the
2-thioxoimidazolidin-4-one A-subunit, but due to its lack of
potency (Jurkat IC50 >20 lM; Table 1) a series of simple substituted
phenyl based derivatives were designed and investigated.
Compounds 7–15 (Table 1) follow an independent 2, 3, 4 substi-
tution pattern on a benzene A-ring with derivative 15 (4-OMe)
demonstrating activity against isolated perforin protein in our Jur-
kat assay (IC50 = 9.36 lM). The remaining methoxy isomers (13,
14) showed no detectable inhibition, suggesting that substitution
para to the connecting thiophene B-subunit is essential for activity.
Prompted by this encouraging result and with derivative 15 pro-
viding an H-bond acceptor moiety, we looked to introduce an
NH2, OH and CN group at positions 3 and 4 accordingly. Isomers
16 (3-NH2) and 17 (4-NH2) both have comparable activity
Compounds 58–63 (Scheme 1) encompass a variety of A-ring
moieties (such as an alcohol, a methanethiol and various sulfon-
amides). These were all accessed through a key Suzuki coupling
step from key intermediate 5 with the corresponding substituted
boronate, as according to the compounds of Table 1. Isobenzofu-
ran-1(3H)-one dimer (71) was prepared in the same manner.
Bromide 64 was commercially available and was converted to
iodide 65 via a copper-mediated halogen exchange reaction as
adapted from literature procedure13 (Scheme 4). Boronate 66 was
synthesised from corresponding bromide intermediate 5 in the
presence of bis(pinacolato)diboron and KOAc and subsequently
coupled with iodide 65 utilising Suzuki methodology to yield pyr-
idyl carboxamide 67 in low yield.
Finally, the preparation of 4-pyridyl-containing target 70 began
with the Suzuki-coupling of 4-bromopyridine 68 with thiophene-
2-boronic acid, as described by Effenberger et al.,19 to furnish 4-
(2-thienyl)pyridine 69 in high yield. Isobenzofuran-1(3H)-one 4
was then installed through treatment with AgNO3 and KF in the
presence of a palladium-complex, as previously discussed, to afford
4-pyridyl derivative 70 in 27% yield (Scheme 1).
(IC50s = 13.97 and 11.82 lM, respectively), showing that substitu-
tion at the 3-position is tolerated in this particular case. This is con-
firmed further by 3-hydroxyl-containing compound 18 in which a
2-fold increase in potency is achieved (IC50 = 5.89 lM). Looking at
3-CN derivative 20 in comparison, activity is lost altogether sug-
gesting that an H-bond donor may be required in this position
for activity. In contrast, 4-OH containing compound 19 loses all
activity whilst 4-CN containing compound 21 (IC50 = 6.87 lM)
retains potency similar to that of 18. This reinforces the argument
in that an H-bond acceptor at position 4 is more favourable and
perhaps necessary for activity to exist in this series (15 and 21 vs
19).
Compounds 22 and 23 were designed with a carboxamide moi-
ety installed at positions 3 and 4, respectively. Substitution at posi-
tion 3 was well tolerated giving rise to an IC50 = 2.97 lM—2-fold
greater than our previously most active compound 18. However
when the primary amide is moved to position 4, a dramatic
increase in the ability to inhibit perforin lytic activity is seen. Ben-
zene-4-carboxamide 23 has
greater than lead thioxoimidazolidinone 2 (Figs. 1 and 2) against
isolated perforin (0.18 M vs 0.78 M, respectively). Furthermore,
the corresponding pyridine-4-carboxamide 67 is also one of our
most potent compounds (IC50 = 0.92 M). Although at the outset
a potency approximately 4-fold
Structure–activity relationships: Based on our previous studies
described above, we hypothesised that selected substitutions on
a benzene or pyridyl ring could potentially occupy the same space
as the thioxoimidazolidinone pharmacophore, thereby mimicking
the network of hydrogen bond donors/acceptors required for
l
l
l
a decision was made to retain the more potent isobenzofuranone
C-subunit, for completeness the analogous isoindolin-1-one (23a)